Health minister faces questions on implications of UK-EU deal for healthcare
26 January 2021
Peers will quiz health minister Edward Argar and health experts tomorrow (Wednesday 27 January) about implications for healthcare and medicines of the UK-EU Trade and Cooperation Agreement.
The House of Lords EU Environment Sub-Committee continues its latest inquiry - Future UK-EU relations: energy, environment and health - by hearing from :
At 9.45 a.m.
- Kate Ling, Senior European Policy Manager, NHS Confederation
- Fiona Loud, Policy Director, Kidney Care UK
- Emlyn Samuel, Director of Policy, Cancer Research UK
- Dr Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry
Likely questions and areas for discussion include:
- How do you assess the arrangements for reciprocal healthcare that have been established?
- Are there any gaps or patient groups who are disadvantaged?
- Has the Government clarified rules for supplying prescription and over-the-counter medicines to Northern Ireland after the one-year grace period?
Are conditions in place to allow UK and EU researchers to cooperate on clinical trials and other health research?
At 11.00 a.m.
- Edward Argar, Minister of State, Department for Health and Social Care
Likely questions for the minister and areas for discussion include:
- How will the Trade and Cooperation Agreement benefit the UK’s healthcare system?
- Can UK citizens still access free healthcare when travelling or living in the EU?
- Are you content that the Agreement’s provisions on health security cooperation allow for effective joint working to address cross-border health risks?
- What steps are you taking to ensure that the UK’s healthcare system can access the workers it needs at all professional levels?
The evidence session will be live on Parliament TV.